Exposing cancer, featuring Cyriac Roeding of Earli
We can make cancer cells tell us exactly where they are.
Consumer internet entrepreneurs lack many of the skills for the life sciences revolution – or do they? Cyriac Roeding, CEO and co-founder of Earli, shows us what his team of bioengineers are accomplishing by applying fast-learning software development discipline to hard life science problems. Earli’s mouse and canine models are producing exciting results inducing cancer cells to expose their locations, enabling precision medicine to pinpoint malignant from benign many months earlier than state-of-the-art techniques. “I love the idea of having multiple shots on goal… rather than spending a billion dollars on small molecule development,” says Cyriac.
As expeditiously as it has progressed, the Earli story is not without its difficult periods, including the death of a gifted co-founder. “First, I cried… I [had become] very close to him. As brilliant a scientist as he was, he was an even more wonderful human being. I loved this man,” shares Cyriac. “Our team rallied behind the whole situation,” and we learn how Cyriac, his co-founder, and the Earli team reinforced their commitment to save lives as quickly as they can.
Tune in wherever podcasts are available.
📺 Watch on Youtube:
🧠 Relevant Links:
- Episode home (this page)
- Cyriac Roeding on LinkedIn
- Earli (company)
- Listen with your favorite podcast service
- Watch this show on Youtube
- Show notes
- Live transcript and static transcript 👇 (when available)